cosopt sine augndropar, lausn 20 mg/ml+5 mg/ml
santen oy* - dorzolamidum hýdróklóríð; timololum maleat - augndropar, lausn - 20 mg/ml+5 mg/ml
methotrexate pfizer (methotrexate wyeth) tafla 2,5 mg
pfizer aps - methotrexatum inn - tafla - 2,5 mg
dorzolamide/timolol alvogen augndropar, lausn 20mg/ml+5 mg/ml
alvogen ehf. - dorzolamidum hýdróklóríð; timololum maleat - augndropar, lausn - 20mg/ml+5 mg/ml
duokopt (joz) augndropar, lausn 20 mg/ml + 5 mg/ml
laboratoires thea s.a.s. - dorzolamidum hýdróklóríð; timololum maleat - augndropar, lausn - 20 mg/ml + 5 mg/ml
intuniv
takeda pharmaceuticals international ag ireland branch - guanfacín hýdróklóríð - attention deficit disorder með ofvirkni - antiadrenergic agents, centrally acting, antihypertensives, - intuniv is indicated for the treatment of attention deficit hyperactivity disorder (adhd) in children and adolescents 6 17 years old for whom stimulants are not suitable, not tolerated or have been shown to be ineffective. intuniv verður að vera notað sem hluti af alhliða kynlÍf meðferð áætlun, venjulega þar á meðal sálfræðilega, mennta og félagslega mælist.
oxycodone/naloxone alvogen (oxycodone/naloxone ratiopharm) forðatafla 10 mg/5 mg
alvogen ehf. - oxycodonum hýdróklóríð; naloxonum hýdróklóríð - forðatafla - 10 mg/5 mg
oxycodone/naloxone alvogen (oxycodone/naloxone ratiopharm) forðatafla 20 mg/10 mg
alvogen ehf. - oxycodonum hýdróklóríð; naloxonum hýdróklóríð - forðatafla - 20 mg/10 mg
oxycodone/naloxone alvogen (oxycodone/naloxone ratiopharm) forðatafla 5 mg/2,5 mg
alvogen ehf. - oxycodonum hýdróklóríð; naloxonum hýdróklóríð - forðatafla - 5 mg/2,5 mg
oxycodone/naloxone alvogen (oxycodone/naloxone ratiopharm) forðatafla 40 mg/20 mg
alvogen ehf. - oxycodonum hýdróklóríð; naloxonum hýdróklóríð - forðatafla - 40 mg/20 mg
narcostop stungulyf, lausn 5 mg/ml
le vet b.v.* - atipamezolum hýdróklóríð - stungulyf, lausn - 5 mg/ml